4M Therapeutics Inc.

United States
Hastings, Minnesota, United States

Company profile

4M Therapeutics Inc. company profile

4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential. We focus on targets implicated in a wide array of disorders and indications. We apply unique insights from our living human brain cell platform, which was developed through a collaborative effort between Harvard, MIT, and the University of Washington) to identify and design more effective and safer therapeutics. The safety and efficacy of our lead compound, 4MT2001, have been demonstrated through in-human safety assessments and genetic target validation conducted by external researchers. These findings are further supported by our comprehensive in vitro and in vivo..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2021-01-20

Headquarters

Headquarters
Hastings, Minnesota, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Seed / 2025-08-22
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
2
Articles
10

Founders and investors

Founders

Ben WilliamsPablo Lapuerta

Lead investors

SYNGAP RESEARCH FUND

Investors

LvlUp VenturesSYNGAP RESEARCH FUND

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.